Cold Contact Urticaria Treatment With Rilonacept

NCT02171416 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Cold Contact Urticaria

Interventions

DRUG: Rilonacept
DRUG: Placebo

Sponsor

Charite University, Berlin, Germany

Collaborators

[object Object]